Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III Study of Fibrin Pad vs Standard of Care for Severe Soft Tissue Bleeding in Surgery
2008-004835-39Phase 3Completed
- Sponsor
- OMRIX Biopharmaceuticals, Inc.
- Start
- Oct 2008
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised trial in Not applicable comparing Fibrin Pad with Standard of care (2 arms). Primary endpoint: Primary hemostasis endpoint. Started Oct 2008; status: completed.
02
Drugs
Fibrin Pad
03
Conditions
Not applicable
Beyond the preview
Go deeper on 2008-004835-39.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-004835-39.